.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

David S. Siegel, MD, PhD

EP. 1: Treatment Approaches in Newly Diagnosed Multiple Myeloma

July 17th 2015

EP. 2: High-Risk Versus Low-Risk Multiple Myeloma

July 17th 2015

EP. 3: Multiple Myeloma: Considerations in Stem Cell Transplantation

July 17th 2015

EP. 4: Resistance to Multiple Myeloma Maintenance Therapy

July 17th 2015

EP. 5: Panobinostat in Relapsed/Refractory Multiple Myeloma

July 17th 2015

EP. 6: Pomalidomide and Carfilzomib in Refractory Multiple Myeloma

July 17th 2015

EP. 7: Role of Carfilzomib in Multiple Myeloma

July 17th 2015

EP. 8: Monoclonal Antibodies in Multiple Myeloma

July 17th 2015

EP. 9: Immunomodulatory Agents in Multiple Myeloma

July 17th 2015